Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00915837 · ClinicalTrials.gov registry record · Phase 1

Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema

A Phase 1 study of Diabetic Macular Edema, sponsored by SurModics.

Completed
Registry status
Phase 1
Development phase
31
Enrollment target
4
Study locations

NCT00915837 is a Phase 1 study of Diabetic Macular Edema that has completed, run by SurModics. The registered enrollment target is 31 participants, below the 3,794-participant average among 63 other Diabetic Macular Edema trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00915837, a Phase 1 study of Diabetic Macular Edema, has completed, sponsored by SurModics.

COMPLETED
Registry status
Phase 1
Development phase
31 participants
Enrollment target
4
Study locations

Study Summary

This Phase 1 study will evaluate the safety, tolerability and duration of effect of a helical intravitreal triamcinolone implant for the treatment of diabetic macular edema over a three-year period.

Conditions Studied

Diabetic Macular Edema

Interventions

  • DRUG triamcinolone acetonide

Study Locations (4)

Arizona

  • Retinal Consultants of Arizona - Phoenix

California

  • California Retina Consultants - Santa Barbara

Michigan

  • Kresege Eye Institute - Detroit

Minnesota

  • VitreoRetinal Surgery, PA - Edina

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2005-06
Est. Completion 2009-05
Phase Phase 1

Sponsor

SurModics

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00915837

The ClinicalTrials.gov registry entry for NCT00915837 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,794-participant average among 63 other Diabetic Macular Edema trials with a reported enrollment target (99% lower). The listed sponsor is SurModics, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetic Macular Edema appearing as the primary indexed condition, and to 1 intervention - of which triamcinolone acetonide is the first listed.

NCT00915837 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Arizona, California, Michigan.

Frequently Asked Questions

What is clinical trial NCT00915837 about?

NCT00915837 is a clinical study titled "Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema". This Phase 1 study will evaluate the safety, tolerability and duration of effect of a helical intravitreal triamcinolone implant for the treatment of diabetic macular edema over a three-year period.

What is the current status of trial NCT00915837?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 31 participants. The study started on 2005-06. Estimated completion is 2009-05.

What conditions does trial NCT00915837 study?

This clinical trial studies the following conditions: Diabetic Macular Edema.

What interventions are being tested in trial NCT00915837?

The interventions under investigation include: triamcinolone acetonide (DRUG).

Who is sponsoring clinical trial NCT00915837?

This trial is sponsored by SurModics, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00915837 being conducted?

This trial has 4 study locations across Arizona, California, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetic Macular Edema

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetic Macular Edema

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.